Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review
- Wednesday, May 15, 2019, 5:40
- Finance
- Add a comment
NEW BRUNSWICK, N.J., May 15, 2019 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will host a meeting today with industry analysts to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023. The company will also discuss its…
Source: https://www.prnewswire.com:443/news-releases/johnson–johnson-outlines-strategy-to-deliver-above-market-growth-at-2019-pharmaceutical-business-review-300850399.html
About the Author
adminasapcorp has written 41279 stories on this site.